Mark H. Moss, MD close
Mark H. Moss, MD

Mark H. Moss, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Mark Moss is the Director of the Allergy and Clinical Immunology fellowship program and board-certified in both Allergy and Immunology and Pediatrics. His medical interests include asthma and atopic dermatitis.


Pediatric Allergy, Asthma and Immunology

UW Health Clinics

East Clinic
(608) 265-1280 | (800) 323-8942 | Map
West Clinic
(608) 263-6180 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital (primary)

UW School of Medicine and Public Health

Department of Medicine

Department of Pediatrics

Professional Certifications and Education

Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Internship University of Wisconsin Hospital and Clinics, Madison, WI
Medical School University of Wisconsin - Madison, Madison, WI, 1994


Madison Magazine Top Docs 2016

Madison Magazine Top Docs 2016

Best Doctors® in America 2015

Madison Magazine Top Docs 2014

Best Doctors® in America 2014

Best Doctors® in America 2013

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.


Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.

Programs & Conditions

  • Allergic Rhinitis
  • Anaphlaxis
  • Atopic Dermatitis/Eczema
  • Drug Allergies
  • Food Allergy
  • Immunodeficiency Disorders
  • Insect Sting Allergy
  • Preschool Wheezing
  • Recurrent Sinus Infection
  • Uticaria

Dr. Moss’ research interests include childhood asthma, allergic rhinitis and allergy immunotherapy.

PubMed Articles
Viswanathan RK Moss MH Mathur SK . Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria. Allergy Asthma Proc. 2013 Sep-Oct;34(5):446-52
[PubMed ID: 23998242]
Thomas A Moss MH . Children at risk for food-related anaphylaxis should carry two doses of epinephrine. J Pediatr. 2010 Nov;157(5):861
[PubMed ID: 20955858]
Lemanske RF Jr Mauger DT Sorkness CA Jackson DJ Boehmer SJ Martinez FD Strunk RC Szefler SJ Zeiger RS Bacharier LB Covar RA Guilbert TW Larsen G Morgan WJ Moss MH Spahn JD Taussig LM . Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010 Mar 18;362(11):975-85
[PubMed ID: 20197425]
Sorkness CA Lemanske RF Jr Mauger DT Boehmer SJ Chinchilli VM Martinez FD Strunk RC Szefler SJ Zeiger RS Bacharier LB Bloomberg GR Covar RA Guilbert TW Heldt G Larsen G Mellon MH Morgan WJ Moss MH Spahn JD Taussig LM . Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol. 2007 Jan;119(1):64-72
[PubMed ID: 17140647]
Moss MH . Immunotherapy: first do no harm. Immunol Allergy Clin North Am. 2005 May;25(2):421-39, viii
[PubMed ID: 15878464]
Need Help Selecting a Doctor?